We have a request from our nuc med department to provide a vial of 23.4% sodium chloride for QC testing on one of their kits. Is anyone else doing this? If not, what are you using as an alternative (kit or QC method)?

Additional information:

With Topex meter dose being discontinued, what is everyone switching to?
Our buyers showed us unit dose hurricaine one 0.5 ml- does that meet all provider needs?

Hi everyone! We are in the beginning stages of converting to adopting NRFit connectors across our health system. Has anyone else converted? Interested in any feedback or lessons learned if willing to share! I reviewed this discussion board and it appears this same question was last posed in April 2023 and at that time there seemed to be a lot of facilities interested or in the beginning stages. Thank you!

We have seen an uptick in reactions to Emend, with two in April (1.5% of cases) and four in June (7.7% of cases). Reactions included chest tightness, facial flushing, and itching.

Has anyone else noticed an increased incidence of Emend reactions?

NDC: 72205-083-01
Lot: CSE09034A
Exp: 8/31/27

NDC: 72205-083-01
Lot: CSE10035A
Exp: 9/30/27

Hi all,

Can you share guidance for dilution instructions of oral potassium chloride solution in pediatric patients? Manufacturers of 20 meq/ 15ml formulation recommend diluting in at least 120 ounces of water, which is too much fluid for most of our pediatric patients. What is your current dilution instructions for neonates and pediatric patients?

Thank you in advance,

Mirella Cardarelli

Hi all-

What is your standard workflow for drug library utilization when the patient comes from the OR to recovery? Do you have an "anesthesia mode" on your pumps that allow for no guardrails, and the expectation is that nursing switch over to whatever appropriate care area once in recovery/patient is stable? Or do you have an alternate workflow? Thanks in advance for your thoughts!

Liz Rebo

Hello MSOS Members! For those attending the upcoming ASHP Pharmacy Futures meeting in Charlotte, NC, ISMP's session will be this Sunday 1:30 - 2:30 pm ET in Room E219A Level 2. We will also have an informal meet and greet from 2:45 - 3:45 pm ET in Room 218 Level 2. Hope to see you there!

Hello everyone,

For any hospitals with over 300 beds, what is your med safety reporting/meeting structure?

Do you have a separate Med Safety committee? If yes, what is its oversight committee? Does it go to P&T, another overall hospital quality group, or something else?

Or is your Med Safety report out/discussion part of a different group (i.e., not a stand alone committee). In this case, how do you organize report outs vs granular safety event discussions?

Any information/details would be greatly appreciated.

Thank you!

-Saduf

Hi Everyone,

I'm reaching out with a question raised by our IV team regarding the placement of labels on compounded IVPB products.

Specifically, where do you place the IV label—on the front or the back of the bag? If placed on the front, does the label cover the name of the diluent? Currently, our practice is inconsistent—some technicians place the label on the front of the IVPB, while others apply it to the back. When placed on the front, the label sometimes covers the name of the diluent, which has led to questions about whether this is preferred or should be avoided.

We have identified opportunities with Ultomiris/Soliris REMS requirements, noteably with:
• Meningococcal vaccine series prior to administration, booster after 1 year, and every 2-3 years after
• Antimicrobial prophylaxis required if above not met

We are interested to see what other sites are doing to ensure compliance.
Thanks!
Maria Cumpston, PharmD, CPPS
Medication Safety Officer & Compliance Director
WVU Hospitals
304-598-4000 ext 73356